期刊文献+

抑制Toll样受体4对apoE^(-/-)小鼠动脉粥样硬化病变的影响 被引量:3

Effect of Inhibition of Toll-like Receptor 4 on The Development of Atherosclerosis in Apolipoprotein E Knockout (apoE^(-/-)) Mice
下载PDF
导出
摘要 通过Toll样受体4(TLR4)抑制剂表没食子儿茶素没食子酸酯(EGCG)对TLR4途径的抑制,研究apoE-/-小鼠TLR4及多种炎症因子的表达和动脉粥样硬化病变程度的改变,以探讨TLR4途径在动脉粥样硬化病变发生中的作用.5周龄雄性apoE-/-小鼠50只,随机分成4组:基础饮食组对照组(n=12)、高脂饮食组对照组(n=12)、基础饮食+EGCG组(n=13)、高脂饮食+EGCG组(n=13).给药14周后处死动物,从主动脉根部连续冰冻切片,油红O染色观察主动脉窦处动脉粥样硬化(As)斑块面积,定量分析主动脉粥样硬化斑块大小及占管腔的面积百分比,采用Realtime-PCR检测主动脉TLR4mRNA和CD14mRNA的表达,蛋白质印迹检测TLR4和CD14蛋白表达,ELISA检测小鼠血清中单核细胞趋化蛋白-1(MCP-1),肿瘤坏死因子-α(TNF-α)浓度.研究结果提示:EGCG显著减轻apoE-/-主动脉窦部的动脉粥样硬化病变,高脂对照组的主动脉窦AS斑块面积为(2.37±0.08)mm2,高脂饲料+EGCG组的主动脉窦AS斑块的面积为(1.05±0.13)mm2,EGCG组小鼠主动脉窦粥样斑块面积比相应对照组明显减少(P<0.05),高脂饮食+EGCG组小鼠TLR4蛋白表达显著降低(P<0.05),MCP-1,TNF-α的含量减少,与高脂饮食对照组相比差异有显著性(P<0.05).TLR4信号转导途径在高脂所致的AS发生当中有着重要作用,该信号途径的激活至少是AS发生当中的一个重要环节. It is known that (-)-Epigallocatechin-3-gallate (EGCG) is the inhibitor of TLR4 signaling pathway activation. To investigate a possible role of TLR4 signaling pathway in the development of atherosclerosis, the effects of EGCG on the development of atherosclerosis, the expression of TLR4 and inflammatory cytokine production in apoE^-/- mice was investigated. Fifty male apoE^-/- mice (5wk old) were divided into four groups: basic diet group (control group), high-fat diet group (control group), EGCG + basic diet group (EGCG group), and high-fat diet + EGCG group (EGCG group). EGCG (10 mg/kg) was injected intraperitoneally every day. Areas of aortic plaque areas were measured by oil red O staining. Western blot was used to detect the expression of TLR4 and CD14 in mouse aorta. The expression of TLR4 mRNA and CD14 mRNA were detected by Real-time PCR. Serum concentrations of MCP-1 and TNF-α were determined with ELISA. Compared with high-fat diet group, EGCG groups showed marked decreases in aortic atherosclerosis (P 〈 0.05), concomitantly with significant decreases in levels of the expression of TLR4, TNF-α and MCP-1. The mean lesion area was (2.37 ±0.08) mm^2 in the high-fat diet + EGCG group, whereas the atherosclerotic lesion was only (1.05 ± 0.13) mm^2 in the high-fat diet + EGCG group. The TLR4 expression was obviously higher in high-fat diet group than that in other groups (P 〈 0.05). Compared with high-diet group, the serum concentrations of MCP-1 and TNF-α were significantly decreased in EGCG groups (P 〈 0.05). These results suggest that TLR4 signaling pathway may play an important role in the development of atherosclerosis in apoE^-/- mice induced by high-fat diet.
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2009年第9期1165-1171,共7页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金资助项目(30470720)~~
关键词 动脉粥样硬化 TOLL样受体4 单核细胞趋化蛋白-1 肿瘤坏死因子-Α atherosclerosis, Toll-like receptor 4, MCP-1, TNF-α
  • 相关文献

参考文献16

  • 1Kaperonis E A, Liapis C D, Kakisis J D, et al. Infammation and atherosclerosis. Eur J Vasc Endovasc Surg, 2006, 31(4): 386-393.
  • 2Adam E, Mullick Peter S, Tobias Linda K, et al. Toll-like receptors and atherosclerosis. Immun Res, 2006, 34(3): 193-209.
  • 3Shi W, Wang N J, Shih D M, et al. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res, 2000, 86(10): 1078- 1084.
  • 4丁晶真,张蔚.绿茶成分心血管保护机制研究进展[J].药物流行病学杂志,2006,15(6):340-343. 被引量:8
  • 5Youn H S, Lee J Y, Saitoh S I, et al. Suppression of MyD88- and TRIF-dependent signaling pathways of toll-like receptor by epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem Pharm, 2006, 72(7): 850-859.
  • 6Pasterkamp G, Van Keulen J K, De Kleijn D P. Role of Toll-like receptor 4 in the initiation and progression of atheroselerotie disease. Eur J Clin Invest, 2004, 34(5): 297-299.
  • 7Vink A, Schoneveld A H, van der Meer J J, et al. In vivo evidence for a role of Toll-Like Receptor 4 in the development of intimal lesions. Circulation, 2002, 106(15): 1985- 1990.
  • 8Schoneveld A H, Hoefer I, Sluijter J P, et al. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis, 2008, 197(1): 95- 104.
  • 9Xu X H, Shah P K, Faure E, et al. Toll-like receptor-4 is expressed by macrophages in routine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation, 2001, 104 (25): 3103-3108.
  • 10Edfeldt K, Swedenborg J, Hansson G K, et al. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation, 2002, 105(10): 1158-1161.

二级参考文献70

  • 1Mitsuzatwa H, Wada I, Sano H, et al. Extracellular Toll-like receptor 2 region containing Ser40-Ile64 but not Cys30-Ser39 is critical for the recognition of Staphylococcus ameus peptidoglycan. [ J ]. J Biol Chem, 2001,276 (44) : 41350-41356.
  • 2Ellingsen E, Morath S, Flo T, et al. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid : involvement of Toll-like receptors and CD14. [ J ]. Med Sci Monit, 2002, 8 (5) :149-156.
  • 3Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. [J]. Clin Chim Acta, 2002, 323(1-2) :59-72.
  • 4Mirlashari MR, Lyberg T. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis. [ J ]. Meal Sci Monit,2003,9(8) :316-324.
  • 5Wooten RM, Morrison TB, Weis JH, et al. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. [J] .J Immunol, 1998,160( 11 ) : 5485-5492.
  • 6Vignal C, Guerardel Y, Kremer L, et al. Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. [ J ]. J Immunol, 2003,171 (4) : 2014-2023.
  • 7Compton T, Kurt-Jones EA, Boehme KW, et al. Human eytomegalovirus activates inflammatory eytokine responses via CD14 and Toll-like receptor 2. [J] .J Virol,2003,77(8):4588-4596.
  • 8Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. [J]. Nat Genet, 2000, 25(2) : 187-191.
  • 9Song P1, Abraham TA, Park Y, et al. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. [ J ]. Invest Ophthalmol Vis Sci, 2001,42(12) : 2867-2877.
  • 10Backhed F, Meijer L, Normark S, et al. TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. [J]. Cell Microbiol,2002, 4(8) :493-501.

共引文献11

同被引文献53

  • 1杨清武,牟玲,王琳,王景周,高东,周红杰,向静.普罗布考对氧化修饰低密度脂蛋白诱导的人内皮细胞TOLL样受体4表达及单核内皮细胞黏附功能的影响[J].中国临床康复,2005,9(7):75-77. 被引量:2
  • 2陈临溪.丙丁酚防治动脉粥样硬化新进展[J].国外医学(生理病理科学与临床分册),1996,16(4):299-300. 被引量:6
  • 3Candido R, Sfivastava P, Cooper ME, et al. Diabetes mellitus: a cartlio- vascular disease [ J ]. CurrOpinlnves@Drugs, 2003,4(9):1088- 094.
  • 4Ross R. Atherosclerosis-an inflammatory disease [ J ]. N Engl J Med, 1999, 340 (2) : 115-126.
  • 5Hansson GK, Libby P. Innate and adaptive immunity in the pathogenesis of atherosclercois [ J ]. Circulation Research, 2002, 91 : 281-291.
  • 6Munick AE, Tobias PS, Curtiss LK. Toll-like receptors and atheroselerosis [ J ]. Immunologic Research, 2006, 34 (3) : 193-209.
  • 7Xu XH, Shah PK, Faure E, et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerodc plaques and up- regulated by oxidized LDL [J]. Circulation, 2001, 104:3 103-108.
  • 8Padhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common int]ammatory basis [ J ] ? Eur Heart J, 2003, 23:831-834.
  • 9Michelsen KS, Doherty TM, Shah PK, et al. An emerging bridge from innate immunity to atherogenesis [ J ]. J lmmunol, 2004, 173 : 5 901-907.
  • 10Reyna SM, Ghosh S, Tantiwong P, et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects [ J ]. Diabetes, 2008, 57 (10): 2595-602.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部